title: International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials.
abstract: Human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2 were among the first human retroviruses discovered in the early 1980's. The International Retrovirology Association is an organized effort that fostered the efforts of scientists and clinicians to form interdisciplinary groups to study this group of retroviruses and their related diseases. The Association promotes excellent science, patient education, and fosters the training of young scientists to promote "bench-to-bedside" research. The International Conference on Human Retrovirology: HTLV and Related Viruses sponsored by the Association supports clinicians and researchers in the exchange of research findings and stimulation of new research directions. This years conference will be held from June 22 to 25, in Montego Bay, Jamaica http://www.htlvconference.org.jm/. Since its inception in 1988, these conferences have provided a highly interactive forum for the global community of HTLV scientists. This is of particular importance as HTLV research enters its third decade and a new generation of scientists takes over this important work. Many of the scientists attending the meeting will be from developing countries where HTLV is endemic, consistent with the history of international collaborations that have characterized HTLV research. The International Conference on Human Retrovirology provides a unique opportunity for researchers of all disciplines interested in HTLV infections to meet their peers and to address the questions facing clinicians and scientists who study retroviruses, like HTLV.
authors.affiliation: Laboratory Medicine and Epidemiology/Biostatistics, University of California at San Francisco and Blood Systems Research Institute, San Francisco, California, USA. murphy@itsa.ucsf.edu
authors.forename: Edward
authors.initials: E
authors.lastname: Murphy
authors.forename: Steven
authors.initials: S
authors.lastname: Jacobson
authors.forename: Genoveffa
authors.initials: G
authors.lastname: Franchini
authors.forename: Graham P
authors.initials: GP
authors.lastname: Taylor
authors.forename: Barrie
authors.initials: B
authors.lastname: Hanchard
authors.forename: Owen
authors.initials: O
authors.lastname: Morgan
authors.forename: Michael
authors.initials: M
authors.lastname: Lairmore
mesh_terms: D035843:Biomedical Research; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D006800:Deltaretrovirus Infections / Q000188:drug therapy; D015368:Human T-lymphotropic virus 1; D015367:Human T-lymphotropic virus 2; D006801:Humans; D038622:Internationality; D012190:Retroviridae; D012192:Retroviridae Infections / Q000188:drug therapy; D012958:Societies, Scientific